CDER Adds Gaucher Disease to 2017 Guidance Agenda Post author:Sam Post published:April 20, 2017 Post category:Drug Industry Daily CDER updated its guidance agenda for 2017, adding an item on Gaucher Disease. Source: Drug Industry Daily You Might Also Like Rare Diseases, RWD, Supply Chain Headline CDER’s Priority List June 14, 2022 UPenn Sues Genentech for Patent Infringement Over Four Breast Cancer Drugs February 2, 2022 Gilead Settles With GSK for $1.25 Million Plus Royalties Over Viiv Patent Dispute February 2, 2022
